keyword
https://read.qxmd.com/read/38647259/a-kinetic-model-reveals-the-critical-gating-motifs-for-donor-substrate-loading-into-actinobacillus-pleuropneumoniae-n-glycosyltransferase
#1
JOURNAL ARTICLE
Zhiqiang Hao, Qiang Guo, Wenjie Peng, Lin-Tai Da
Soluble N -glycosyltransferase from Actinobacillus pleuropneumoniae (ApNGT) catalyzes the glycosylation of asparagine residues, and represents one of the most encouraging biocatalysts for N -glycoprotein production. Since the sugar tolerance of ApNGT is restricted to limited monosaccharides ( e.g. , Glc, GlcN, Gal, Xyl, and Man), tremendous efforts are devoted to expanding the substrate scope of ApNGT via enzyme engineering. However, rational design of novel NGT variants suffers from an elusive understanding of the substrate-binding process from a dynamic point of view...
April 22, 2024: Physical Chemistry Chemical Physics: PCCP
https://read.qxmd.com/read/38647032/prediction-of-the-essential-intermolecular-contacts-for-side-binding-of-vasp-on-f-actin
#2
JOURNAL ARTICLE
Fikret Aydin, Harshwardhan H Katkar, Alisha Morganthaler, Alyssa J Harker, David R Kovar, Gregory A Voth
Vasodilator-stimulated phosphoprotein (VASP) family proteins play a crucial role in mediating the actin network architecture in the cytoskeleton. The Ena/VASP homology 2 (EVH2) domain in each of the four identical arms of the tetrameric VASP consists of a loading poly-Pro region, a G-actin-binding domain (GAB), and an F-actin-binding domain (FAB). Together, the poly-Pro, GAB, and FAB domains allow VASP to bind to sides of actin filaments in a bundle, and recruit profilin-G-actin to processively elongate the filaments...
April 22, 2024: Cytoskeleton
https://read.qxmd.com/read/38641700/effects-of-urban-induced-mutations-on-ecology-evolution-and-health
#3
REVIEW
Marc T J Johnson, Irtaqa Arif, Francesco Marchetti, Jason Munshi-South, Rob W Ness, Marta Szulkin, Brian C Verrelli, Carole L Yauk, Daniel N Anstett, Warren Booth, Aude E Caizergues, Elizabeth J Carlen, Anthony Dant, Josefa González, César González Lagos, Madeleine Oman, Megan Phifer-Rixey, Diana J Rennison, Michael S Rosenberg, Kristin M Winchell
Increasing evidence suggests that urbanization is associated with higher mutation rates, which can affect the health and evolution of organisms that inhabit cities. Elevated pollution levels in urban areas can induce DNA damage, leading to de novo mutations. Studies on mutations induced by urban pollution are most prevalent in humans and microorganisms, whereas studies of non-human eukaryotes are rare, even though increased mutation rates have the potential to affect organisms and their populations in contemporary time...
April 19, 2024: Nature Ecology & Evolution
https://read.qxmd.com/read/38641404/the-sos1-inhibitor-mrtx0902-blocks-kras-activation-and-demonstrates-antitumor-activity-in-cancers-dependent-on-kras-nucleotide-loading
#4
JOURNAL ARTICLE
Niranjan Sudhakar, Larry Yan, Fadia Qiryaqos, Lars D Engstrom, Jade Laguer, Andrew Calinisan, Allan Hebbert, Laura Waters, Krystal Moya, Vickie Bowcut, Laura Vegar, John M Ketcham, Anthony Ivetac, Christopher R Smith, J David Lawson, Lisa Rahbaek, Jeffrey Clarine, Natalie Nguyen, Barbara Saechao, Cody Parker, Adam J Elliott, Darin Vanderpool, Leo He, Laura D Hover, Julio Fernandez-Banet, Silvia Coma, Jonathan A Pachter, Jill Hallin, Matthew A Marx, David M Briere, James G Christensen, Peter Olson, Jacob Haling, Shilpi Khare
KRAS is the most frequently mutated oncogene in human cancer and facilitates uncontrolled growth through hyperactivation of the RTK/MAPK pathway. The Son of Sevenless homolog 1 (SOS1) protein functions as a guanine nucleotide exchange factor (GEF) for the RAS subfamily of small GTPases and represents a druggable target in the pathway. Using a structure-based drug discovery approach, MRTX0902 was identified as a selective and potent SOS1 inhibitor that disrupts the KRAS:SOS1 protein-protein interaction to prevent SOS1-mediated nucleotide exchange on KRAS and translates into an anti-proliferative effect in cancer cell lines with genetic alterations of the KRAS-MAPK pathway...
April 19, 2024: Molecular Cancer Therapeutics
https://read.qxmd.com/read/38641232/combining-anabolic-loading-and-raloxifene-improves-bone-quantity-and-some-quality-measures-in-a-mouse-model-of-osteogenesis-imperfecta
#5
JOURNAL ARTICLE
Amy Creecy, Dyann Segvich, Corinne Metzger, Rachel Kohler, Joseph M Wallace
Osteogenesis imperfecta (OI) increases fracture risk due to changes in bone quantity and quality caused by mutations in collagen and its processing proteins. Current therapeutics improve bone quantity, but do not treat the underlying quality deficiencies. Male and female G610C+/- mice, a murine model of OI, were treated with a combination of raloxifene and in vivo axial tibial compressive loading starting at 10 weeks of age and continuing for 6 weeks to improve bone quantity and quality. Bone geometry and mechanical properties were measured to determine whole bone and tissue-level material properties...
April 17, 2024: Bone
https://read.qxmd.com/read/38638373/a-revised-classification-of-primary-iron-overload-syndromes
#6
JOURNAL ARTICLE
Yasuaki Tatsumi, Motoyoshi Yano, Shinya Wakusawa, Hiroaki Miyajima, Tetsuya Ishikawa, Shinsaku Imashuku, Atsuko Takano, Wataru Nihei, Ayako Kato, Koichi Kato, Hisao Hayashi, Kentaro Yoshioka, Kazuhiko Hayashi
BACKGROUND AND AIMS: The clinical introduction of hepcidin25 (Hep25) has led to a more detailed understanding of its relationship with ferroportin (FP) and divalent metal transporter1 in primary iron overload syndromes (PIOSs). In 2012, we proposed a classification of PIOSs based on the Hep25/FP system, which consists of prehepatic aceruloplasminemia, hepatic hemochromatosis (HC), and posthepatic FP disease (FP-D). However, in consideration of accumulated evidence on PIOSs, we aimed to renew the classification...
April 28, 2024: Journal of Clinical and Translational Hepatology
https://read.qxmd.com/read/38634223/are-asymptomatic-carriers-of-otc-deficiency-always-asymptomatic-a-multicentric-retrospective-study-of-risk-using-the-ucdc-longitudinal-study-database
#7
REVIEW
Kuntal Sen, Rima Izem, Yuelin Long, Jiji Jiang, Laura L Konczal, Robert J McCarter, Andrea L Gropman, Jirair K Bedoyan
BACKGROUND: Ornithine transcarbamylase deficiency (OTCD) due to an X-linked OTC mutation, is responsible for moderate to severe hyperammonemia (HA) with substantial morbidity and mortality. About 80% of females with OTCD remain apparently "asymptomatic" with limited studies of their clinical characteristics and long-term health vulnerabilities. Multimodal neuroimaging studies and executive function testing have shown that asymptomatic females exhibit limitations when stressed to perform at higher cognitive load and had reduced activation of the prefrontal cortex...
April 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38630551/efficacy-of-pembrolizumab-and-biomarker-analysis-in-patients-with-wgs-based-intermediate-to-high-tumor-mutational-load-results-from-the-drug-rediscovery-protocol
#8
JOURNAL ARTICLE
Birgit S Geurts, Laurien J Zeverijn, Lindsay V M Leek, Jade M van Berge Henegouwen, Louisa R Hoes, Hanneke van der Wijngaart, Vincent van der Noort, Joris van de Haar, Annemiek van Ommen-Nijhof, Marleen Kok, Paul Roepman, Anne M L Jansen, Wendy W J de Leng, Maja J A de Jonge, Ann Hoeben, Carla M L van Herpen, Hans M Westgeest, Lodewyk F A Wessels, Henk M W Verheul, Hans Gelderblom, Emile E Voest
PURPOSE: To evaluate efficacy of pembrolizumab across multiple cancer types harboring different levels of Whole-Genome Sequencing (WGS)-based tumor mutational load (TML; total of non-synonymous mutations across the genome) in patients included in the Drug Rediscovery Protocol (NCT02925234). PATIENTS AND METHODS: Patients with solid, treatment-refractory, microsatellite-stable tumors were enrolled in cohort A: breast cancer TML 140-290, cohort B: tumor-agnostic cohort TML 140-290, and cohort C: tumor-agnostic cohort TML >290...
April 17, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38628952/case-series-of-people-with-hiv-on-the-long-acting-combination-of-lenacapavir-and-cabotegravir-call-for-a-trial
#9
JOURNAL ARTICLE
Monica Gandhi, Lucas Hill, Janet Grochowski, Alexander Nelson, Catherine A Koss, Francis Mayorga-Munoz, Jon Oskarsson, Mary Shiels, Ann Avery, Laura Bamford, Jillian Baron, William R Short, Corrilynn O Hileman
BACKGROUND: Injectable cabotegravir (CAB)/rilpivirine (RPV) is the only combination long-acting (LA) antiretroviral regimen approved for HIV. RPV may not be effective among individuals with non-nucleoside reverse transcriptase inhibitor (NNRTI) resistance, which has >10% prevalence in many countries. Lenacapavir (LEN) is an LA capsid inhibitor given every 6 months, but has not been studied in combination with other LA agents. METHODS: We assembled a case series from 4 US academic medical centers where patients with adherence challenges were prescribed LEN subcutaneously every 26 weeks/CAB (+/- RPV) intramuscularly every 4 or 8 weeks...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38627370/tertiary-structure-and-conformational-dynamics-of-the-anti-amyloidogenic-chaperone-dnajb6b-at-atomistic-resolution
#10
JOURNAL ARTICLE
Vasista Adupa, Elizaveta Ustyantseva, Harm H Kampinga, Patrick R Onck
DNAJB6b is a molecular chaperone of the heat shock protein network, shown to play a crucial role in preventing aggregation of several disease-related intrinsically disordered proteins. Using homology modeling and microsecond-long all-atom molecular dynamics (MD) simulations, we show that monomeric DNAJB6b is a transiently interconverting protein cycling between three states: a closed state, an open state (both abundant), and a less abundant extended state. Interestingly, the reported regulatory autoinhibitory anchor between helix V in the G/F1 region and helices II/III of the J-domain, which obstructs the access of Hsp70 to the J-domain remains present in all three states...
April 16, 2024: Nature Communications
https://read.qxmd.com/read/38617356/evidence-for-negative-selection-in-human-primary-fibroblasts-to-tolerate-high-somatic-mutation-loads-upon-treatment-with-multiple-low-doses-of-n-ethyl-n-nitrosourea
#11
Johanna Heid, Ronald Cutler, Shixiang Sun, Moonsook Lee, Alexander Y Maslov, Xiao Dong, Simone Sidoli, Jan Vijg
High-throughput sequencing at the single-cell and single-molecule level has shown that mutation rate is much higher in somatic cells than in the germline, with thousands of mutations accumulating with age in most human tissues. While there is now ample evidence that some of these mutations can clonally amplify and lead to disease, most notably cancer, the total burden of mutations a cell can tolerate without functional decline remains unknown. Here we addressed this question by exposing human primary fibroblasts multiple times to low doses of N-ethyl-N-nitrosourea (ENU) and quantitatively analyzing somatic mutation burden using single-cell whole genome sequencing...
April 7, 2024: bioRxiv
https://read.qxmd.com/read/38617300/endo-reduplication-in-mouse-liver-after-conditional-mutation-of-orc2-and-combined-mutation-of-orc1-and-orc2
#12
Roza K Przanowska, Yuechuan Chen, Takayuki-Okano Uchida, Etsuko Shibata, Xiaoxiao Hao, Isaac Segura Rueda, Kate Jensen, Piotr Przanowski, Anthony Trimboli, Yoshiyuki Shibata, Gustavo Leone, Anindya Dutta
The six subunit Origin Recognition Complex (ORC) is essential for loading MCM2-7 at origins of DNA replication to promote initiation of DNA replication in organisms ranging from S. cerevisiae to humans. In rare instances, as in cancer cell-lines in culture with mutations in ORC1 , ORC2 or ORC5 , or in endo-reduplicating mouse hepatocytes in vivo without ORC1 , DNA replication has been observed in the virtual absence of individual ORC subunits. Although ORC1 is dispensable in the mouse liver for endo-reduplication, because of the homology of ORC1 with CDC6, it could be argued that CDC6 was substituting for ORC1 to restore functional ORC...
April 6, 2024: bioRxiv
https://read.qxmd.com/read/38608935/emergence-of-hiv-1-drug-resistance-mutations-among-children-and-adolescents-undergoing-prolonged-antiretroviral-therapy-in-guangxi
#13
JOURNAL ARTICLE
Xianwu Pang, Hongyan Lu, Qin He, Kailing Tang, Jie Ma, Siya Chen, Jinghua Huang, Ningye Fang, Haomin Xie, Guanghua Lan, Shujia Liang
OBJECTIVE: Antiretroviral therapy (ART) has been implemented in Guangxi for a long time, and no reports about HIV drug resistance mutation (DRM) among children and adolescents experiencing virological failure after ART. This study aimed to analyze HIV DRM prevalence, patterns, and influencing factors among children and adolescents experiencing virologic failure after ART in Guangxi. METHODS: We collected samples from a total of 491 HIV-infected individuals under 18 years old experiencing virological failure after ART from 14 cities in Guangxi...
April 10, 2024: Journal of Global Antimicrobial Resistance
https://read.qxmd.com/read/38604585/a-validated-in-house-assay-for-hiv-drug-resistance-mutation-surveillance-from-dried-blood-spot-specimens
#14
JOURNAL ARTICLE
Bronwyn Neufeld, Chantal Munyuza, Alexandria Reimer, Rupert Capiña, Emma R Lee, Marissa Becker, Paul Sandstrom, Hezhao Ji, François Cholette
Despite increasing scale-up of antiretroviral therapy (ART) coverage, challenges related to adherence and HIV drug resistance (HIVDR) remain. The high cost of HIVDR surveillance is a persistent challenge with implementation in resource-constrained settings. Dried blood spot (DBS) specimens have been demonstrated to be a feasible alternative to plasma or serum for HIVDR genotyping and are more suitable for lower resource settings. There is a need for affordable HIVDR genotyping assays which can amplify HIV-1 sequences from DBS specimens, particularly those with low viral loads, at a low cost...
April 9, 2024: Journal of Virological Methods
https://read.qxmd.com/read/38601581/cathepsin-l-promotes-oesophageal-squamous-cell-carcinoma-development-and-may-be-associated-with-tumour-associated-macrophages
#15
JOURNAL ARTICLE
Zhenhu Zhang, Jianyu Wang, Yamin Shi, Ben Wang, Dong Wang
BACKGROUND: Oesophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths worldwide because existing treatments are often insufficient. Therefore, new, reliable biomarkers must be identified. CTSL overexpression is closely associated with tumour progression and poor prognosis. However, the role and mechanism of CTSL as an oncogene in ESCC remain unclear. METHODS: Genome-wide association study (GWAS) data were used for Mendelian randomization analysis to investigate the possible relationships between CTSL and ESCC...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38593579/molecular-insights-into-fucr-transcription-factor-to-control-the-metabolism-of-l-fucose-in-bifidobacterium-longum-subsp-infantis
#16
JOURNAL ARTICLE
Xiaojun Yang, Jing Zhang, Jing Zhu, Ruijin Yang, Yanjun Tong
Bifidobacterium longum subsp. infantis commonly colonizes the human gut and is capable of metabolizing L - fucose, which is abundant in the gut. Multiple studies have focused on the mechanisms of L -fucose utilization by B. longum subsp. infantis, but the regulatory pathways governing the expression of these catabolic processes are still unclear. In this study, we have conducted a structural and functional analysis of L - fucose metabolism transcription factor FucR derived from B. longum subsp. infantis Bi-26...
April 3, 2024: Microbiological Research
https://read.qxmd.com/read/38593151/elevated-interleukin-8-expression-by-skin-fibroblasts-as-a-potential-contributor-to-pain-in-women-with-fabry-disease
#17
JOURNAL ARTICLE
Lukas Hofmann, Julia Grüner, Katharina Klug, Maximilian Breyer, Thomas Klein, Vanessa Hochheimer, Laura Wagenhäuser, Erhard Wischmeyer, Nurcan Üçeyler
Fabry disease (FD) is a lysosomal storage disorder of X-linked inheritance. Mutations in the α-galactosidase A gene lead to cellular globotriaosylceramide (Gb3) depositions and triggerable acral burning pain in both sexes as an early FD symptom of unknown pathophysiology. We aimed at elucidating the link between skin cells and nociceptor sensitization contributing to FD pain in a sex-associated manner. We used cultured keratinocytes and fibroblasts of 27 adult FD patients and 20 healthy controls. Epidermal keratinocytes and dermal fibroblasts were cultured and immunoreacted to evaluate Gb3 load...
2024: PloS One
https://read.qxmd.com/read/38591887/a-nucleoid-associated-protein-is-involved-in-the-emergence-of-antibiotic-resistance-by-promoting-the-frequent-exchange-of-the-replicative-dna-polymerase-in-mycobacterium-smegmatis
#18
JOURNAL ARTICLE
Wei L Ng, E Hesper Rego
UNLABELLED: Antibiotic resistance in Mycobacterium tuberculosis exclusively originates from chromosomal mutations, either during normal DNA replication or under stress, when the expression of error-prone DNA polymerases increases to repair damaged DNA. To bypass DNA lesions and catalyze error-prone DNA synthesis, translesion polymerases must be able to access the DNA, temporarily replacing the high-fidelity replicative polymerase. The mechanisms that govern polymerase exchange are not well understood, especially in mycobacteria...
April 9, 2024: MSphere
https://read.qxmd.com/read/38588814/biochemical-characterization-of-e-coli-dnac-variants-that-alter-dnab-helicase-loading-onto-dna
#19
JOURNAL ARTICLE
Sarah D McMillan, James L Keck
DNA replication in E. coli starts with loading of the replicative helicase, DnaB, onto DNA. This reaction requires the DnaC loader protein, which forms a 6:6 complex with DnaB and opens a channel in the DnaB hexamer through which single-stranded DNA is thought to pass. During replication, replisomes frequently encounter DNA damage and nucleoprotein complexes that can lead to replication fork collapse. Such events require DnaB re-loading onto DNA to allow replication to continue. Replication restart proteins mediate this process by recruiting DnaB6 /DnaC6 to abandoned DNA replication forks...
April 6, 2024: Journal of Biological Chemistry
https://read.qxmd.com/read/38587664/role-of-plasma-ebv-dna-load-and-eber-status-on-newly-diagnosed-peripheral-t-cell-lymphoma
#20
JOURNAL ARTICLE
Jing Chen, Jie Zhou, Fei Cheng, Donghe Chen, Fangshu Guan, Enfan Zhang, Jingsong He, Zhen Cai, Yi Zhao
PURPOSE: To explore the prognostic and therapeutic role of Epstein-Barr Virus (EBV) on peripheral T-cell lymphoma (PTCL). METHODS: Totally 262 newly diagnosed PTCL patients who were hospitalized from January 2014 to December 2022 were retrospectively enrolled. Molecular analysis included 31 eligible patients. EBV-encoded RNA (EBER) presence in tumor tissue and EBV DNA levels in patients at baseline (DNA1) and after 4 cycles of chemotherapy (DNA4) were assessed. RESULTS: Our findings revealed that the EBER-positive cohort exhibited significant differences compared to counterparts in overall survival (OS, P = 0...
April 8, 2024: Journal of Cancer Research and Clinical Oncology
keyword
keyword
101882
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.